Skip to main content
. 2020 Nov 5;12(11):1057. doi: 10.3390/pharmaceutics12111057

Table 4.

The chromatographic purities of TAFFB-SO and TAFFB-CO formulations within implants of differing wall thicknesses at 210 and 240 days.

Implants Release Rate (mg/day) Purity at 210 Days (%) Purity at 240 Days (%)
TAFFB-SO 150 µm 0.18 ± 0.03 94.3 88.8
TAFFB-SO 200 µm 0.11 ± 0.04 91.8 86.7
TAFFB-SO 300 µm 0.07 ± 0.02 96.1 93.2
TAFFB-CO 150 µm 0.31 ± 0.06 80.0 63.5
TAFFB-CO 200 µm 0.17 ± 0.07 81.2 67.9
TAFFB-CO 300 µm 0.10 ± 0.02 90.3 79.0